Report Detail

Request for Sample of this report

Medical Devices & Consumables COVID-19 Impact on Global Non-invasive Neuromodulation Device Market Insights and Forecast to 2026

  • RnM4102683
    • |
  • 23 July, 2020
    • |
  • Global
    • |
  • 112 Pages
    • |
  • QYResearch
    • |
  • Medical Devices & Consumables

Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. It is divided into invasive and non-invasive neuromodulation, which includes ETC, Transcranial Electrical Stimulation (tES) and so on.
Market Analysis and Insights: Global Non-invasive Neuromodulation Device Market
The global Non-invasive Neuromodulation Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Non-invasive Neuromodulation Device Scope and Segment
Non-invasive Neuromodulation Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-invasive Neuromodulation Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Neuroelectrics
Magstim
NeuroCare Group
Soterix Medical
Newronika
Rogue Resolutions
Medtronic
Philips Healthcare
Shenzhen Yingchi Technology
Shenzhen Hanix United
Shanghai Qiankang Medical Care Company
TCT Research
EB Neuro SpA
Non-invasive Neuromodulation Device Breakdown Data by Type
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Non-invasive Neuromodulation Device Breakdown Data by Application
Hospital
Clinic
Others
Regional and Country-level Analysis
The Non-invasive Neuromodulation Device market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non-invasive Neuromodulation Device market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Non-invasive Neuromodulation Device Market Share Analysis


1 Study Coverage

  • 1.1 Non-invasive Neuromodulation Device Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Non-invasive Neuromodulation Device Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Non-invasive Neuromodulation Device Market Size Growth Rate by Type
    • 1.4.2 Transcranial Direct Current Stimulation (tDCS)
    • 1.4.3 Transcranial Alternating Current Stimulation (tACS)
    • 1.4.4 Transcranial Pulsed Current Stimulation (tPCS)
    • 1.4.5 Transcranial Random Noise Stimulation (tRNS)
    • 1.4.6 Electroconvulsive therapy (ECT)
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Non-invasive Neuromodulation Device Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Non-invasive Neuromodulation Device Market Size, Estimates and Forecasts
    • 2.1.1 Global Non-invasive Neuromodulation Device Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Non-invasive Neuromodulation Device Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Non-invasive Neuromodulation Device Production Estimates and Forecasts 2015-2026
  • 2.2 Global Non-invasive Neuromodulation Device, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Non-invasive Neuromodulation Device Manufacturers Geographical Distribution
  • 2.4 Key Trends for Non-invasive Neuromodulation Device Markets & Products
  • 2.5 Primary Interviews with Key Non-invasive Neuromodulation Device Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Non-invasive Neuromodulation Device Manufacturers by Production Capacity
    • 3.1.1 Global Top Non-invasive Neuromodulation Device Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Non-invasive Neuromodulation Device Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Non-invasive Neuromodulation Device Manufacturers Market Share by Production
  • 3.2 Global Top Non-invasive Neuromodulation Device Manufacturers by Revenue
    • 3.2.1 Global Top Non-invasive Neuromodulation Device Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Non-invasive Neuromodulation Device Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Non-invasive Neuromodulation Device Revenue in 2019
  • 3.3 Global Non-invasive Neuromodulation Device Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Neuromodulation Device Production by Regions

  • 4.1 Global Non-invasive Neuromodulation Device Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Non-invasive Neuromodulation Device Regions by Production (2015-2020)
    • 4.1.2 Global Top Non-invasive Neuromodulation Device Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Non-invasive Neuromodulation Device Production (2015-2020)
    • 4.2.2 North America Non-invasive Neuromodulation Device Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Non-invasive Neuromodulation Device Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Non-invasive Neuromodulation Device Production (2015-2020)
    • 4.3.2 Europe Non-invasive Neuromodulation Device Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Non-invasive Neuromodulation Device Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Non-invasive Neuromodulation Device Production (2015-2020)
    • 4.4.2 China Non-invasive Neuromodulation Device Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Non-invasive Neuromodulation Device Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Non-invasive Neuromodulation Device Production (2015-2020)
    • 4.5.2 Japan Non-invasive Neuromodulation Device Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Non-invasive Neuromodulation Device Import & Export (2015-2020)

5 Non-invasive Neuromodulation Device Consumption by Region

  • 5.1 Global Top Non-invasive Neuromodulation Device Regions by Consumption
    • 5.1.1 Global Top Non-invasive Neuromodulation Device Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Non-invasive Neuromodulation Device Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Non-invasive Neuromodulation Device Consumption by Application
    • 5.2.2 North America Non-invasive Neuromodulation Device Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Non-invasive Neuromodulation Device Consumption by Application
    • 5.3.2 Europe Non-invasive Neuromodulation Device Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Non-invasive Neuromodulation Device Consumption by Application
    • 5.4.2 Asia Pacific Non-invasive Neuromodulation Device Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Non-invasive Neuromodulation Device Consumption by Application
    • 5.5.2 Central & South America Non-invasive Neuromodulation Device Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Non-invasive Neuromodulation Device Consumption by Application
    • 5.6.2 Middle East and Africa Non-invasive Neuromodulation Device Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Non-invasive Neuromodulation Device Market Size by Type (2015-2020)
    • 6.1.1 Global Non-invasive Neuromodulation Device Production by Type (2015-2020)
    • 6.1.2 Global Non-invasive Neuromodulation Device Revenue by Type (2015-2020)
    • 6.1.3 Non-invasive Neuromodulation Device Price by Type (2015-2020)
  • 6.2 Global Non-invasive Neuromodulation Device Market Forecast by Type (2021-2026)
    • 6.2.1 Global Non-invasive Neuromodulation Device Production Forecast by Type (2021-2026)
    • 6.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Non-invasive Neuromodulation Device Price Forecast by Type (2021-2026)
  • 6.3 Global Non-invasive Neuromodulation Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Non-invasive Neuromodulation Device Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Non-invasive Neuromodulation Device Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Neuroelectrics
    • 8.1.1 Neuroelectrics Corporation Information
    • 8.1.2 Neuroelectrics Overview
    • 8.1.3 Neuroelectrics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Neuroelectrics Product Description
    • 8.1.5 Neuroelectrics Related Developments
  • 8.2 Magstim
    • 8.2.1 Magstim Corporation Information
    • 8.2.2 Magstim Overview
    • 8.2.3 Magstim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Magstim Product Description
    • 8.2.5 Magstim Related Developments
  • 8.3 NeuroCare Group
    • 8.3.1 NeuroCare Group Corporation Information
    • 8.3.2 NeuroCare Group Overview
    • 8.3.3 NeuroCare Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 NeuroCare Group Product Description
    • 8.3.5 NeuroCare Group Related Developments
  • 8.4 Soterix Medical
    • 8.4.1 Soterix Medical Corporation Information
    • 8.4.2 Soterix Medical Overview
    • 8.4.3 Soterix Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Soterix Medical Product Description
    • 8.4.5 Soterix Medical Related Developments
  • 8.5 Newronika
    • 8.5.1 Newronika Corporation Information
    • 8.5.2 Newronika Overview
    • 8.5.3 Newronika Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Newronika Product Description
    • 8.5.5 Newronika Related Developments
  • 8.6 Rogue Resolutions
    • 8.6.1 Rogue Resolutions Corporation Information
    • 8.6.2 Rogue Resolutions Overview
    • 8.6.3 Rogue Resolutions Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Rogue Resolutions Product Description
    • 8.6.5 Rogue Resolutions Related Developments
  • 8.7 Medtronic
    • 8.7.1 Medtronic Corporation Information
    • 8.7.2 Medtronic Overview
    • 8.7.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Medtronic Product Description
    • 8.7.5 Medtronic Related Developments
  • 8.8 Philips Healthcare
    • 8.8.1 Philips Healthcare Corporation Information
    • 8.8.2 Philips Healthcare Overview
    • 8.8.3 Philips Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Philips Healthcare Product Description
    • 8.8.5 Philips Healthcare Related Developments
  • 8.9 Shenzhen Yingchi Technology
    • 8.9.1 Shenzhen Yingchi Technology Corporation Information
    • 8.9.2 Shenzhen Yingchi Technology Overview
    • 8.9.3 Shenzhen Yingchi Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Shenzhen Yingchi Technology Product Description
    • 8.9.5 Shenzhen Yingchi Technology Related Developments
  • 8.10 Shenzhen Hanix United
    • 8.10.1 Shenzhen Hanix United Corporation Information
    • 8.10.2 Shenzhen Hanix United Overview
    • 8.10.3 Shenzhen Hanix United Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Shenzhen Hanix United Product Description
    • 8.10.5 Shenzhen Hanix United Related Developments
  • 8.11 Shanghai Qiankang Medical Care Company
    • 8.11.1 Shanghai Qiankang Medical Care Company Corporation Information
    • 8.11.2 Shanghai Qiankang Medical Care Company Overview
    • 8.11.3 Shanghai Qiankang Medical Care Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Shanghai Qiankang Medical Care Company Product Description
    • 8.11.5 Shanghai Qiankang Medical Care Company Related Developments
  • 8.12 TCT Research
    • 8.12.1 TCT Research Corporation Information
    • 8.12.2 TCT Research Overview
    • 8.12.3 TCT Research Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 TCT Research Product Description
    • 8.12.5 TCT Research Related Developments
  • 8.13 EB Neuro SpA
    • 8.13.1 EB Neuro SpA Corporation Information
    • 8.13.2 EB Neuro SpA Overview
    • 8.13.3 EB Neuro SpA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 EB Neuro SpA Product Description
    • 8.13.5 EB Neuro SpA Related Developments

9 Non-invasive Neuromodulation Device Production Forecast by Regions

  • 9.1 Global Top Non-invasive Neuromodulation Device Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Non-invasive Neuromodulation Device Regions Forecast by Production (2021-2026)
  • 9.3 Key Non-invasive Neuromodulation Device Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Non-invasive Neuromodulation Device Consumption Forecast by Region

  • 10.1 Global Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)
  • 10.2 North America Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Non-invasive Neuromodulation Device Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Non-invasive Neuromodulation Device Sales Channels
    • 11.2.2 Non-invasive Neuromodulation Device Distributors
  • 11.3 Non-invasive Neuromodulation Device Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Non-invasive Neuromodulation Device Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Non-invasive Neuromodulation Device Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Non-invasive Neuromodulation Device Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Non-invasive Neuromodulation Device. Industry analysis & Market Report on COVID-19 Impact on Global Non-invasive Neuromodulation Device is a syndicated market report, published as COVID-19 Impact on Global Non-invasive Neuromodulation Device Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Non-invasive Neuromodulation Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,500.00
    		$7,000.00
    		2,796.50
    		5,593.00
    		3,248.00
    		6,496.00
    		545,510.00
    		1,091,020.00
    		292,495.00
    		584,990.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo